Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05307705 |
| Title | A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Eli Lilly and Company |
| Indications | |
| Therapies |
Abemaciclib + Anastrozole + LOXO-783 Abemaciclib + Exemestane + LOXO-783 Abemaciclib + Letrozole + LOXO-783 Abemaciclib + Fulvestrant + LOXO-783 |
| Age Groups: | senior | adult |
| Covered Countries | USA |
CKB BOOST